Valuation: RAMM Pharma Corp.

Market Cap 11.94L 8L 7L 7L 6L 8.09Cr 12.14L 82.15L 32.15L 4.01Cr 31.81L 31.12L 14Cr P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 5L 3L 3L 3L 3L 3.19Cr 5L 32.37L 12.67L 1.58Cr 12.53L 12.26L 5.46Cr EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
1 month-33.33%
3 months-33.33%
6 months-66.67%
Current year-83.33%
1 month 0
Extreme 0.005
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.8
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Date Insider Type Main position Quantity % Market Cap.
02/06/25 Sell

Chief Executive Officer

46,67,000 3.9091%
21/03/25 Buy

Chief Executive Officer

1,00,000 0.0838%
21/03/25 Buy

Chief Executive Officer

2,00,000 0.1675%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%0.00%-83.33% 8L
+1.93%+3.85%+51.05%+166.24% 1,08900Cr
+0.29%+6.43%+60.47%+52.87% 64TCr
+2.45%+2.77%+39.61%+74.48% 47TCr
-0.04%+10.22%+41.17%+36.56% 36TCr
+0.73%+3.87%+39.70%+44.49% 30TCr
+1.31%+3.59%+19.93%+17.02% 27TCr
-0.45%+3.50%-25.66%-36.53% 23TCr
+4.48%+7.33%+30.47%+66.31% 21TCr
+2.91%+3.10%+18.84%+74.76% 17TCr
Average +1.44%+4.57%+27.56%+41.29% 37.31TCr
Weighted average by Cap. +1.56%+5.14%+39.89%+80.14%

Financials

2024 2025
Net sales 43.42L 30.82L 27.04L 25.18L 23.16L 29Cr 44.16L 2.99Cr 1.17Cr 15Cr 1.16Cr 1.13Cr 50Cr 33.61L 23.85L 20.93L 19.49L 17.93L 23Cr 34.18L 2.31Cr 90.51L 11Cr 89.54L 87.61L 39Cr
Net income -1.65Cr -1.17Cr -1.03Cr -95.71L -88.03L -111.89Cr -1.68Cr -11Cr -4.44Cr -55Cr -4.4Cr -4.3Cr -191.72Cr -89.1L -63.23L -55.49L -51.68L -47.53L -60Cr -90.63L -6.13Cr -2.4Cr -30Cr -2.37Cr -2.32Cr -103.51Cr
Net Debt -6L -4L -4L -4L -3L -4.24Cr -6L -43.06L -16.85L -2.1Cr -16.67L -16.31L -7.27Cr -7L -5L -5L -4L -4L -4.91Cr -7L -49.78L -19.49L -2.43Cr -19.28L -18.86L -8.41Cr
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. RAMM Stock